There was an isolated report by Kaplan who described a female MPNST patient with a BRAF mutation who received Vemurafenib for approximately 4 days, and following this, the tumour had shrunk by 50% [49]. This evidence concerns the gene BRAF and malignant peripheral nerve sheath tumor.